AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2024
Jan 24, 2024
34491_dirs_2024-01-23_24595dc8-e6f6-4a4b-b89c-44d6230a343f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-01-20
Reporting Person: Kelly John Alexander (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-20 | Common Stock | M | 116690 | — | Acquired | 614169 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-20 | Restricted Stock Units | $ | M | 116690 | Disposed | Common Stock (116690) | Direct |
Footnotes
F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
F3: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.